Literature DB >> 19137648

Expression of a B-cell-restricted isoform of CD45 is associated with maturity in rat serosal and connective-tissue mast cells.

Chunping Yu1, Mahin Moghaddami, Graham Mayrhofer.   

Abstract

Fas-associated protein with death domain/mediator of receptor induced toxicity (FADD/MORT1) was first described as a transducer of death receptor signalling but was later recognized also to be important for proliferation of T cells. B-cell lymphoma 3 (Bcl-3) is a relatively little understood member of the nuclear factor (NF)-kappaB family of transcription factors. We recently found that Bcl-3 is up-regulated in T cells from mice where FADD function is blocked by a dominant negative transgene (FADD-DN). To understand the importance of this, we generated FADD-DN/bcl-3(-/-) mice. Here, we report that T cells from these mice show massive cell death and severely reduced proliferation in response to T-cell receptor (TCR) stimulation in vitro. Transgenic coexpression of Bcl-2 (FADD-DN/bcl-3(-/-)/vav-bcl-2 mice) rescued the survival but not the proliferation of T cells. FADD-DN/bcl-3(-/-) mice had normal thymocyte numbers but reduced numbers of peripheral T cells despite an increase in cycling T cells in vivo. However, activation of the classical NF-kappaB and extracellular regulated kinase (ERK) pathways and expression of interleukin (IL)-2 mRNA upon stimulation were normal in T cells from FADD-DN/bcl-3(-/-) mice. These data suggest that FADD and Bcl-3 regulate separate pathways that both contribute to survival and proliferation in mouse T cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19137648      PMCID: PMC2612556          DOI: 10.1111/j.1365-2567.2008.02930.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  46 in total

Review 1.  Mast cell modulation of immune responses to bacteria.

Authors:  R Malaviya; S N Abraham
Journal:  Immunol Rev       Date:  2001-02       Impact factor: 12.988

2.  Regulation of mast cell signaling through high-affinity IgE receptor by CD45 protein tyrosine phosphatase.

Authors:  K Murakami; S Sato; S Nagasawa; T Yamashita
Journal:  Int Immunol       Date:  2000-02       Impact factor: 4.823

3.  Recruitment and proliferation of CD4+ T cells in synovium following adoptive transfer of adjuvant-induced arthritis.

Authors:  Llewellyn D J Spargo; Leslie G Cleland; Michaelia P Cockshell; Graham Mayrhofer
Journal:  Int Immunol       Date:  2006-04-18       Impact factor: 4.823

Review 4.  CD45: new jobs for an old acquaintance.

Authors:  J M Penninger; J Irie-Sasaki; T Sasaki; A J Oliveira-dos-Santos
Journal:  Nat Immunol       Date:  2001-05       Impact factor: 25.606

Review 5.  Mast cell-committed progenitors.

Authors:  Yukihiko Kitamura; Akihiko Ito
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-01       Impact factor: 11.205

6.  TU-572, a potent and selective CD45 inhibitor, suppresses IgE-mediated anaphylaxis and murine contact hypersensitivity reactions.

Authors:  T Hamaguchi; A Takahashi; A Manaka; M Sato; H Osada
Journal:  Int Arch Allergy Immunol       Date:  2001-12       Impact factor: 2.749

7.  Identification of mast cell progenitors in adult mice.

Authors:  Ching-Cheng Chen; Michele A Grimbaldeston; Mindy Tsai; Irving L Weissman; Stephen J Galli
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-08       Impact factor: 11.205

8.  Characterization of thoracic duct cells that transfer polyarthritis.

Authors:  L D Spargo; L G Cleland; S J Wing; J S Hawkes; G Mayrhofer
Journal:  Clin Exp Immunol       Date:  2001-12       Impact factor: 4.330

9.  MHC II+ CD45+ cells from synovium-rich tissues of normal rats: phenotype, comparison with macrophage and dendritic cell lineages and differentiation into mature dendritic cells in vitro.

Authors:  Mahin Moghaddami; Leslie G Cleland; Graham Mayrhofer
Journal:  Int Immunol       Date:  2005-07-19       Impact factor: 4.823

10.  An inactivating point mutation in the inhibitory wedge of CD45 causes lymphoproliferation and autoimmunity.

Authors:  R Majeti; Z Xu; T G Parslow; J L Olson; D I Daikh; N Killeen; A Weiss
Journal:  Cell       Date:  2000-12-22       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.